Download Free Hysteria In Remission Book in PDF and EPUB Free Download. You can read online Hysteria In Remission and write the review.

Included in this deluxe collection are the artist's contributions to such legendary anthologies as "ZAP, Snatch, Arcade, Cocaine Comix" and many others. in full color.
Patients with hysterical conversion present with striking physical symptoms such as weakness, sensory disorders or memory loss, that suggest a neurological disease but which show no evidence of brain and central nervous system damage. Although it is now over one hundred years since Breuer and Freud published their seminal Studies on Hysteria(1895) the story of hysteria remains controversial - even its existence as a viable clinical entity has been repeatedly questioned. Despite renewed interest over the past decade, most publications report little or no empirical research from the cognitive or clinical neurosciences. This is surprising given that the explanation of hysteria is still one where "the very notions of mind and body, and the boundaries and bridges between them are constantly challenged and reconstituted" (Porter, 1993). The rush to explain hysteria in terms of psychodynamics has so far proved elusive. Rather than developing further theories of hysteria, it is essential to charcterise those domains of normal volition and motor and sensory control that may be impaired, and from which it is possible to interpret observed symptoms. Only then will it be possible to provide a cognitively motivated account of how psychological mechanisms can translate (convert) into physical symptoms. As in other areas of psychiatry, it seems beneficial when explaining psychiatric phenomena to consider whether impairment to normal psychological phenomena can be used to construct a rational account of the underlying pathology. The aim of this special issue is to bridge the void left by the traditional over-reliance on psychodynamic accounts by emphasising putative cognitive and neuropsychological accounts of this puzzling and cotnroversial condition.ial to charcterise those domains of normal volition and motor and sensory control that may be impaired, and from which it is possible to interpret observed symptoms. Only then will it be possible to provide a cognitively motivated account of how psychological mechanisms can translate (convert) into physical symptoms. As in other areas of psychiatry, it seems beneficial when explaining psychiatric phenomena to consider whether impairment to normal psychological phenomena can be used to construct a rational account of the underlying pathology. The aim of this special issue is to bridge the void left by the traditional over-reliance on psychodynamic accounts by emphasising putative cognitive and neuropsychological accounts of this puzzling and cotnroversial condition.
These days, hysteria is known as a discredited diagnosis that was used to group and pathologize a wide range of conditions and behaviors in women. But for a long time, it was seen as a legitimate category of medical problem—and one that, originally, was applied to men as often as to women. In On Hysteria, Sabine Arnaud traces the creation and rise of hysteria, from its invention in the eighteenth century through nineteenth-century therapeutic practice. Hysteria took shape, she shows, as a predominantly aristocratic malady, only beginning to cross class boundaries (and be limited to women) during the French Revolution. Unlike most studies of the role and status of medicine and its categories in this period, On Hysteria focuses not on institutions but on narrative strategies and writing—the ways that texts in a wide range of genres helped to build knowledge through misinterpretation and recontextualized citation. Powerfully interdisciplinary, and offering access to rare historical material for the first time in English, On Hysteria will speak to scholars in a wide range of fields, including the history of science, French studies, and comparative literature.
Managing Treatment-Resistant Depression: Road to Novel Therapeutics defines TRD for readers, discussing the clinical and epidemiological predictors, economic burden and neurobiological factors. In addition, staging methods for treatment resistance are fully covered in this book, including serotonin specific reuptake inhibitors, serotonin norepinephrine reuptake inhibitors, other classes of antidepressants, including tricyclic antidepressants and monoamine oxidase inhibitors, augmentation strategies, and newer antidepressant treatments like ketamine and esketamine. In addition, evidence supporting the use of psychotherapies and neuromodulation strategies are also reviewed. Written by top experts in the field, this book is the first of its kind to review all methods of treatment for TRD. - Defines Treatment-Resistant Depression and Staging Treatment Intensity - Includes Treatment-Resistant Depression options for children, adolescents, geriatrics, during pregnancy, and during post-partum and menopause transitions - Discusses the use of Ketamine and Esketamine for treatment-resistant depression